Agile Therapeutics PE Ratio 2013-2023 | AGRX
Current and historical p/e ratio for Agile Therapeutics (AGRX) from 2013 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agile Therapeutics PE ratio as of April 23, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Agile Therapeutics PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-03-25 |
0.60 |
|
0.00 |
| 2023-12-31 |
1.95 |
$-9.84 |
0.00 |
| 2023-09-30 |
2.40 |
$-13.33 |
0.00 |
| 2023-06-30 |
2.95 |
$-39.56 |
0.00 |
| 2023-03-31 |
11.20 |
$-172.91 |
0.00 |
| 2022-12-31 |
11.35 |
$-356.00 |
0.00 |
| 2022-09-30 |
14.85 |
$-751.00 |
0.00 |
| 2022-06-30 |
58.25 |
$-1,084.50 |
0.00 |
| 2022-03-31 |
419.00 |
$-1,349.00 |
0.00 |
| 2021-12-31 |
976.20 |
$-1,560.00 |
0.00 |
| 2021-09-30 |
1922.20 |
$-1,560.00 |
0.00 |
| 2021-06-30 |
2660.00 |
$-1,560.00 |
0.00 |
| 2021-03-31 |
4160.00 |
$-1,400.00 |
0.00 |
| 2020-12-31 |
5740.00 |
$-1,200.00 |
0.00 |
| 2020-09-30 |
6080.00 |
$-1,000.00 |
0.00 |
| 2020-06-30 |
5560.00 |
$-800.00 |
0.00 |
| 2020-03-31 |
3720.00 |
$-820.00 |
0.00 |
| 2019-12-31 |
5000.00 |
$-840.00 |
0.00 |
| 2019-06-30 |
2920.00 |
$-860.00 |
0.00 |
| 2019-03-31 |
3020.00 |
$-1,020.00 |
0.00 |
| 2018-12-31 |
1151.80 |
$-1,160.00 |
0.00 |
| 2018-09-30 |
733.00 |
$-1,300.00 |
0.00 |
| 2018-06-30 |
988.00 |
$-1,520.00 |
0.00 |
| 2018-03-31 |
5140.00 |
$-1,720.00 |
0.00 |
| 2017-12-31 |
5380.00 |
$-1,840.00 |
0.00 |
| 2017-09-30 |
8920.00 |
$-1,840.00 |
0.00 |
| 2017-06-30 |
7500.00 |
$-1,940.00 |
0.00 |
| 2017-03-31 |
6410.00 |
$-2,000.00 |
0.00 |
| 2016-12-31 |
11400.00 |
$-2,020.00 |
0.00 |
| 2016-09-30 |
13960.00 |
$-2,000.00 |
0.00 |
| 2016-06-30 |
15220.00 |
$-2,300.00 |
0.00 |
| 2016-03-31 |
12420.00 |
$-2,480.00 |
0.00 |
| 2015-12-31 |
19520.00 |
$-2,740.00 |
0.00 |
| 2015-09-30 |
13480.00 |
$-3,140.00 |
0.00 |
| 2015-06-30 |
17180.00 |
$-2,980.00 |
0.00 |
| 2015-03-31 |
18540.00 |
$-3,140.00 |
0.00 |
| 2014-12-31 |
12280.00 |
$-2,500.00 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
